As the Year of the Rat stumbled into an unexpected start, all of us are deeply concerned with the latest development of the novel coronavirus (nCoV).
Since its outbreak, Evonik has been closely monitoring situation. In order to protect our employees and ensure safe operations, we are taking various measures according to the national and local disease control requirements.
We are pleased to share with you that all 10 plants and 4 offices of Evonik China have resumed full operation on February 10. Meanwhile, we are pulling together the global procurement and supply chain resources of the Evonik Group to support the production of our customers and partners. The whole business team of Evonik is ready to assist you in any emergent order for disease control purposes, seeking every possibility of fast delivery in line with local policies. It is our responsibility to provide professional, high-quality services to every customer and partner, anytime and anywhere.
Fighting against epidemic demands immediate action. In the past few weeks, many of our customers and partners were among the first movers to make donations and efforts to help control the spread of nCoV. Deeply impressed and inspired by them, Evonik also made our own contributions to the battle against nCoV through joint donation and free supply of raw materials urgently needed on the frontline.
Up to now, zero case of nCoV infection has been reported neither in Evonik China nor in other regions Evonik operates. We are doing everything within our power to keep the record. At the very beginning of the outbreak, Evonik China has assembled a regional emergency response team to guide the disease control work and the implementation of the production and operation plan. Our business teams maintain close contact with our customers and partners to fulfill their needs promptly. Our function teams are joining forces in employee communication, PPE procurement and distribution, supplier emergency management, etc. to protect our employees and operations, while at the same time to reduce the impacts to our customers and partners to the minimum.
“Customer proximity is the basis for mutual success”. This philosophy has guided our business in China for years. Despite of the uncertainties amid the epidemic, we promise to deal with any potential risks in operation and shall make our best efforts to minimize the possible impact to the supply to the Chinese customers caused by the outbreak.
Last but not the least, we express sincere gratitude to you for your confidence, understanding and support to Evonik during this hard time. Together, we shall prevail. We firmly believe that the nCoV epidemic will soon be conquered and we will all embrace a safer, healthier and better future!
February 11, 2020
Evonik is one of the world leaders in specialty chemicals. The focus on more specialty businesses, customer-oriented innovative prowess and a trustful and performance-oriented corporate culture form the heart of Evonik’s corporate strategy. They are the lever for profitable growth and a sustained increase in the value of the company. Evonik benefits specifically from its customer proximity and leading market positions. Evonik is active in over 100 countries around the world. In fiscal 2018, the enterprise with more than 32,000 employees generated sales of €13.3 billion and an operating profit (adjusted EBITDA) of €2.15 billion from continuing operations.
Evonik regards China as one of the driving forces of the global economy and we consequently endeavor to grow our business here. The company now employs over 2,500 employees and has in total of 10 production sites in China.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.